Biofrontera Inc. Increase (Decrease) in Accounts Payable, Related Parties
Biofrontera Inc. (BFRI) reported Increase (Decrease) in Accounts Payable, Related Parties of -$3.71 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties · last filed 2026-08-13
- Biofrontera Inc. increase (decrease) in accounts payable, related parties for the quarter ending 2026-06-30 was -$217.00K.
- Biofrontera Inc. increase (decrease) in accounts payable, related parties for the quarter ending 2026-03-31 was -$3.50M.
- Biofrontera Inc. increase (decrease) in accounts payable, related parties for the quarter ending 2025-12-31 was $2.83M, a 67.95% increase year-over-year.
- Biofrontera Inc. increase (decrease) in accounts payable, related parties for the quarter ending 2025-09-30 was $1.32M, a 5.93% decline year-over-year.
- Biofrontera Inc. increase (decrease) in accounts payable, related parties for fiscal 2025 was -$533.00K.
- Biofrontera Inc. increase (decrease) in accounts payable, related parties for fiscal 2024 was -$355.00K, a 108.09% decline from fiscal 2023.
- Biofrontera Inc. increase (decrease) in accounts payable, related parties for fiscal 2023 was $4.39M.
| Period end | Increase (Decrease) in Accounts Payable, Related Parties 3 month | Increase (Decrease) in Accounts Payable, Related Parties 6 month | Increase (Decrease) in Accounts Payable, Related Parties 9 month | Increase (Decrease) in Accounts Payable, Related Parties 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$217.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$3.71M 10-Q · filed 2026-08-13 | -$889.00K derived: sum of 3 quarters · filed 2026-08-13 | $427.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$3.50M 10-Q · filed 2026-05-14 | -$672.00K derived: sum of 2 quarters · filed 2026-05-14 | $644.00K derived: sum of 3 quarters · filed 2026-05-14 | -$1.34M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $4.14M derived: sum of 2 quarters · filed 2026-03-19 | $2.16M derived: sum of 3 quarters · filed 2026-08-13 | -$533.00K 10-K · filed 2026-03-19 |
| 2025-09-30 | $1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$664.00K derived: sum of 2 quarters · filed 2026-08-13 | -$3.36M 10-Q · filed 2025-11-12 | -$1.68M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$1.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$4.67M 10-Q · filed 2026-08-13 | -$2.99M derived: sum of 3 quarters · filed 2026-08-13 | -$1.59M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$2.69M 10-Q · filed 2026-05-14 | -$1.01M derived: sum of 2 quarters · filed 2026-05-14 | $387.00K derived: sum of 3 quarters · filed 2026-05-14 | -$1.22M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $3.08M derived: sum of 2 quarters · filed 2026-03-19 | $1.47M derived: sum of 3 quarters · filed 2026-03-19 | -$355.00K 10-K · filed 2026-03-19 |
| 2024-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$212.00K derived: sum of 2 quarters · filed 2025-11-12 | -$2.04M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | -$1.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$3.44M 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$1.82M 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | $4.39M 10-K · filed 2025-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |